Published January 26, 2018
Almost a full eleven months ago we wrote about a coming change of fortune for biotech stocks. It appeared back in March 2017 that the group, after 18 months of pain and an almost 50% plunge in price, was about to launch a new bullish period. It took quite a bit longer than expected, but we are pleased to announce that this week the group finally achieved full-out liftoff! (more…)